I now have comprehensive content from the textbooks. Let me compile a thorough, well-organized response.
Pediatrics: Fever, Cyanosis, and Neural Tube Defects
1. PEDIATRIC FEVER
Definition
Fever is defined as a rectal temperature of ≥38.0°C (100.4°F). It is the most common chief complaint among pediatric patients in the emergency department. The vast majority of febrile illness in children is viral, self-limited, and benign. - Rosen's Emergency Medicine, p. 3152
Age-Based Risk Stratification
The approach to fever is stratified by age because risk is a continuum tied to immunologic and vaccination milestones:
| Age Group | Key Concerns |
|---|
| 0-28 days | Highest risk; immature immune system; SBI rate 6-10%; empiric antibiotics indicated |
| 1-3 months | Still high risk; risk-stratification tools used (Rochester, Boston, Philadelphia criteria) |
| 3-36 months | Lower risk post-vaccination; clinical assessment drives workup |
| >3 years | Much lower risk of SBI without a focus |
Etiology by Age
0-8 days: Group B Streptococcus, Listeria, E. coli, HSV, enteroviruses, RSV
1-3 months: H. influenzae, S. pneumoniae, N. meningitidis, E. coli, RSV, influenza
3-36 months: S. pneumoniae, N. meningitidis, E. coli, varicella, enteroviruses, mononucleosis
>3 years: S. pneumoniae, N. meningitidis, adenovirus, influenza, EBV
Serious Bacterial Infection (SBI)
SBI = growth of pathogenic bacteria in a previously sterile site: UTI, bacteremia, meningitis, osteomyelitis, septic arthritis, bacterial pneumonia. The most common cause of SBI at all pediatric ages is UTI.
Key points:
- Neonates (0-28 days): Empiric treatment with ampicillin + gentamicin or cefotaxime is indicated
- HSV: Empiric acyclovir for neonates with maternal history of genital herpes, cutaneous vesicles, fever + seizure, transaminitis, or coagulopathy
- RSV/influenza do NOT lower the risk of concurrent SBI in infants <28 days, but significantly reduce SBI risk in older infants and children
- Fever + petechiae = risk for meningococcal infection; admit and treat parenterally if CBC/CRP/PCT abnormal
- Fever + sickle cell disease = functional asplenia, high risk for bacteremia from encapsulated organisms - admit and treat
- Fever in oncology patients = broad-spectrum antibiotics promptly after blood culture
Investigations
- CRP and procalcitonin (PCT) predict bacterial illness better than WBC alone; PCT >0.5 ng/mL warrants treatment
- Urine culture: Most reliable via bladder catheterization in non-toilet-trained children; bag specimens have up to 85% false positive rate
- Positive urine culture = >50,000 CFU/mL single uropathogen from catheterization/suprapubic aspirate
- Lumbar puncture: Not indicated for well-appearing child with a simple febrile seizure; indicated if signs of meningitis
Febrile Seizures
Simple febrile seizures carry a very low risk of meningitis; LP is not routinely needed. - Rosen's Emergency Medicine, p. 3153
2. CYANOSIS IN PEDIATRICS (Neonatal/Infant)
Types of Cyanosis
- Central cyanosis - involves mucous membranes; indicates true hypoxemia or abnormal hemoglobin
- Peripheral cyanosis (acrocyanosis) - involves digits only; may be benign/normal in newborns
Common Causes
| Category | Examples |
|---|
| Cyanotic congenital heart disease | Tetralogy of Fallot, Transposition of great arteries, Tricuspid atresia, Total anomalous pulmonary venous return (TAPVR), Truncus arteriosus (the "5 T's") |
| Pulmonary disease | RDS, pneumonia, meconium aspiration - cause respiratory distress, grunting, retractions |
| CNS/Sepsis | Apnea, bradycardia, lethargy, seizures with cyanosis |
| Methemoglobinemia | Minimal distress despite cyanosis; blood remains chocolate-colored in air |
Clinical Assessment
- Measure BP in all four extremities - pressure difference between upper and lower may signal coarctation of aorta
- Neonates with cardiac cyanosis: tachypnea but minimal respiratory distress
- Neonates with pulmonary cyanosis: grunting, retractions, respiratory distress
- Neonates with sepsis/CNS cyanosis: apnea, bradycardia, lethargy, seizures
The Hyperoxia Test
Place infant on 100% O2 for 20 minutes and check PaO2:
- Cyanotic heart disease: PaO2 does NOT rise >20 mmHg (right-to-left shunting persists)
- Pulmonary/sepsis: PaO2 improves significantly with oxygen
- Methemoglobinemia: No response to oxygen; blood remains chocolate-colored when exposed to air
- Tintinalli's Emergency Medicine, p. 865
Treatment of Cyanosis
- Primary objective: treat intercurrent illness, exclude non-cardiac causes, diagnose cyanotic CHD
- Caution with oxygen in CHD: Oxygen is a pulmonary vasodilator - it may cause pulmonary overcirculation or steal systemic flow in patent ductus arteriosus (PDA)-dependent lesions
- Reserve O2 for: signs of inadequate tissue perfusion, unknown diagnosis (diagnostic + therapeutic), known CHD with SpO2 significantly below baseline
- Ductal-dependent lesions require prostaglandin E1 (PGE1) to maintain PDA patency
- Neonates tolerate SpO2 in the 70s due to oxygen-avid fetal hemoglobin in mixing lesions
- Tintinalli's Emergency Medicine, p. 866
Tet Spells (Tetralogy of Fallot)
Caused by right ventricular outflow tract obstruction → right-to-left shunting through VSD.
Management (stepwise):
- 100% O2 via non-rebreathing mask
- Calm the child; place in parent's arms
- Knee-chest position (flexed knees) - increases SVR and venous return
- Morphine 0.1-0.2 mg/kg IM/SC/IV (or intranasal fentanyl/midazolam as alternatives)
- Normal saline 5-10 mL/kg bolus (increase preload)
- Sodium bicarbonate 2 mEq/kg IV (treat acidosis, promote pulmonary vasodilation)
- Propranolol 0.2 mg/kg IV (relieve infundibular spasm)
- Phenylephrine 2-10 mcg/kg/min (increase SVR)
- Ketamine (sedation + increased SVR)
- Refractory: neuromuscular blockade + rapid-sequence intubation
- Tintinalli's Emergency Medicine, p. 866
Right-Sided Aortic Arch (clue on CXR)
Seen with: Truncus arteriosus, Transposition of great arteries, Tetralogy of Fallot, Tricuspid atresia, TAPVR - mnemonic: "5 T's with right arch"
3. NEURAL TUBE DEFECTS (NTDs)
Embryology
NTDs result from failure of neural tube closure during the first month of embryonic life (weeks 3-4). - Langman's Medical Embryology, p. 98
Closure failure sites:
| Defect | Location of Failure |
|---|
| Anencephaly | Cranial end fails to close → most of brain fails to form |
| Encephalocele | Cranial closure defect |
| Spina bifida | Cervical region caudally |
| Craniorachischisis | Head + cervical/thoracic spine |
Most common site: Lumbosacral region (most susceptible to genetic and environmental factors)
Types of Spina Bifida
- Spina bifida occulta - vertebral arch defect, no herniation, often clinically silent
- Meningocele - meninges herniate through defect, spinal cord normal
- Myelomeningocele - spinal cord + meninges herniate; most severe; causes paralysis and bladder/bowel dysfunction proportional to the spinal level
Anencephaly
Lethal defect; most diagnosed prenatally. Incompatible with survival beyond a few hours after birth.
Consequences
- Large lumbosacral myelomeningocele: partial or complete lower limb paralysis, impaired bladder and bowel continence
- Associated with hydrocephalus and Arnold-Chiari malformation type II
Etiology - Multifactorial
Chromosomal causes: Trisomy 13, Trisomy 18 (NTD incidence ~5-10% in each)
Syndromal: Meckel-Gruber syndrome (AR) - encephalocele + polycystic kidneys + polydactyly
Most cases: Isolated, multifactorial inheritance - Emery's Medical Genetics, p. (NTD section)
Genetic: Mutations in VANGL genes (planar cell polarity pathway - regulates convergent extension/neural tube lengthening) are associated with familial NTDs - Langman's Medical Embryology
Epidemiology
- Pre-folic acid fortification in USA: 1 in 1,000 births (1 in 500 in some states)
- Parts of China: as high as 1 in 200 births
- Highest UK incidence in people of Celtic origin
- After folic acid fortification in USA: approximately 1 in 1,500 births
- Recurrence risk for first-degree relatives: up to 4-5% in high-prevalence areas
Prevention - Folic Acid
50-70% of NTDs can be prevented with periconceptional folic acid:
- Dose: 400 mcg/day (the standard in most prenatal vitamins)
- Timing: begin 3 months before conception and continue throughout pregnancy
- Women with a prior NTD-affected pregnancy: 4-5 mg/day (high-dose)
- Goldman-Cecil Medicine; Langman's Medical Embryology, p. 98
Diagnosis
- AFP (alpha-fetoprotein): Elevated in maternal serum and amniotic fluid in open NTDs (ONTD)
- Ultrasound: Primary prenatal diagnostic modality
- Creasy & Resnik's Maternal-Fetal Medicine, p. (NTD section)
Management
- Prenatal: detailed anomaly scan, genetic counseling, multidisciplinary team
- Delivery planning at tertiary center
- Postnatal: surgical closure of myelomeningocele within 24-72 hours ideally
- Long-term: management of hydrocephalus (VP shunt), orthopedic, urology, neurosurgery
Summary Table
| Topic | Key Point |
|---|
| Fever definition | Rectal temp ≥38.0°C (100.4°F) |
| Highest fever risk | Neonates 0-28 days (SBI rate 6-10%) |
| Most common SBI | UTI at all pediatric ages |
| Neonatal empiric ABX | Ampicillin + gentamicin or cefotaxime |
| Cyanosis diagnosis | Hyperoxia test - PaO2 rise <20 mmHg = cardiac |
| Tet spell Rx | Knee-chest + O2 + morphine + fluid |
| NTD prevention | Folic acid 400 mcg/day from 3 months pre-conception |
| NTD timing | Neural tube closes weeks 3-4 of embryonic life |
| Most common NTD | Spina bifida (lumbosacral myelomeningocele) |
| Lethal NTD | Anencephaly |